Cmpx stock forecast.

March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.CMPX: Compass Therapeutics, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Compass Therapeutics, Inc. from Zacks Investment ResearchGreenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing the consensus estimate of ($14.00) by $32.00. The company had revenue of $41.31 million for the quarter, compared to analyst estimates of $40.31 million.Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...

See CAPITAL POWER CORPORATION stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 44.85 0.00 0.00%. The 10 analysts offering 1 year price forecasts for CPX have a max estimate of — and a min estimate of —.Compass Therapeutics Inc. (CMPX) stock has fallen -0.53% while the S&P 500 is higher by 0.02% as of 3:29 PM on Tuesday, Feb 14. CMPX is lower by -$0.02 from the previous closing price of $3.80 on volume of 515,663 shares. Over the past year the S&P 500 is down -5.98% while CMPX is higher by 52.42%. CMPX lost -$0.42 per share the …Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.

According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.The Compass Therapeutics, Inc. stock price gained 2.42% on the last trading day (Friday, 1st Dec 2023), rising from $1.65 to $1.69. During the last trading …Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business. CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ...

Stock Screener; ETF Screener; Comparisons; Explore Alpha Picks ... Compass Therapeutics (CMPX) Investor Presentation - Slideshow. Nov. 23, 2022 6:22 AM ET Compass Therapeutics, Inc. (CMPX) SA ...

If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.WVE. Wave Life Sciences Ltd. 5.31. -0.09. -1.67%. In this article, we will take a look at the 11 best biotech penny stocks to buy now. To see more such companies, go directly to 5 Best Biotech ...Comprehensive selection of real-time charts, which plot movements in the forex, futures and stock markets, with quotes updated continuously throughout the trading day.APRE Stock 12 Months Forecast. $15.00. (300.00% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Aprea Therapeutics in the last 3 months. The average price target is $15.00 with a high forecast of $20.00 and a low forecast of $9.00. The average price target represents a 300.00% change from the last price of $3.75.CMPX Stock Predictions. CMPX Stock Buy or Sell? - Get a free CMPX stock trend analysis report to help you analyze and make a better CMPX stock predictions. The stock analysis service is provided by MarketClub, using their Smart Scan and Trade Triangle technology. It uses technical analysis and the current market condition to give you the best ...PSTX Stock 12 Months Forecast. $12.25. (369.35% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Poseida Therapeutics in the last 3 months. The average price target is $12.25 with a high forecast of $15.00 and a low forecast of $8.00. The average price target represents a 369.35% change from the last price of $2.61.

Dec 1, 2023 · The consensus price target of analysts on Wall Street is $9.17, which implies an increase of 82.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -566.67% off the target high and -384.85% off the low. Compass Therapeutics (CMPX) Stock Forecast & Price Prediction. Estimation of the future price movement of Compass Therapeutics stock, based on various factors such as …According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00. 2 days ago · Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase of 452.07% from the latest price. Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.Typically, the average forecast for the group predicts the S&P 500 climbing by about 10%, which is in line with historical averages. 14h ago The Wall Street Journal

Future criteria checks 0/6. Compass Therapeutics is forecast to grow earnings and revenue by 21.6% and 76.7% per annum respectively while EPS is expected to grow by 25.3% per annum.BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023.

Compass Therapeutics (CMPX) Stock Forecast & Price Target $1.72 0.00 (0.00%) (As of 01:47 PM ET) Compare Today's Range $1.68 $1.72 50-Day Range $1.40 $2.13 52-Week …Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.CompX International, Inc. engages in the manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool stoStock price analysis for Compass Therapeutics, Inc. (CMPX), stock quote, stock research, rsi, macd, support, resistance and most important highlights.Safe & Green Development Corp. $1.95. -0.70. -26.42%. COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information.Compass Therapeutics, Inc. Common Stock (CMPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. What this means: InvestorsObserver gives Compass Therapeutics Inc. (CMPX) an overall rank of 34, which is below average. Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system. March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.CMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023.18 brokerages have issued 1-year price objectives for ChargePoint's shares. Their CHPT share price targets range from $2.00 to $17.00. On average, they expect the company's share price to reach $9.13 in the next year. This suggests a possible upside of 380.1% from the stock's current price.

Stock price analysis for Compass Therapeutics, Inc. (CMPX), stock quote, stock research, rsi, macd, support, resistance and most important highlights.

CMPX Stock Price Chart Interactive Chart > Compass Therapeutics Inc. (CMPX) Company Bio. Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel …

Stock Price Forecast. The 28 analysts offering 12-month price forecasts for APA Corp (US) have a median target of 48.50, with a high estimate of 65.00 and a low estimate of 34.00. The median ...The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecastsGet actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Apexigen APGN Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%. Look out for CMPX's next earnings release expected on November 08, 2023. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year ... Find the latest VOC Energy Trust (VOC) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock analysis for Compass Therapeutics Inc (CMPX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and …Nov 15, 2023 · The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecasts News Ideas Financials Technicals Forecast CMPX chart Today 2.59% 5 days 2.06% 1 month 3.66% 6 months −31.25% Year to date −61.10% 1 year −34.44% 5 years −76.71% All time −76.71% Key stats Market capitalization 252.37M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −0.37 USD Net income −39.225M USD Revenue — Shares floatc1968 kd 99121 57/64 bolt type lock 1k-compx stock locks

66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes Safe & Green Development Corp. $1.95. -0.70. -26.42%. COMP | A complete NASDAQ Composite Index index overview by MarketWatch. View stock market news, stock market data and trading information.66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...Instagram:https://instagram. are there solar powered carsbuy shares of artnvidia share price targetaaa renters insurance southern california The 6 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 6 analysts giving stock ratings to CMPX in the past 3 months. twillow stocknasdaq 100 list The Eterna Therapeutics 52-week low stock price is 0.84, which is 31.1% below the current share price. ... Compass Therapeutics (CMPX), United States, $0.215B ... 1776 to 1976 d quarter worth The average Mind Medicine stock price prediction forecasts a potential upside of 810.6% from the current MNMD share price of $3.02. What is MNMD's forecast return on equity (ROE) for 2023-2026? (NASDAQ: MNMD) forecast ROE is N/A, which is considered weak.March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.